高级检索
    孔德强, 宋昱, 陈布泽. 不同剂量瑞芬太尼联合右美托咪定在高强度聚集超声治疗子宫肌瘤术中麻醉效果的观察[J]. 徐州医科大学学报, 2023, 43(5): 358-361. DOI: 10.3969/j.issn.2096-3882.2023.05.009
    引用本文: 孔德强, 宋昱, 陈布泽. 不同剂量瑞芬太尼联合右美托咪定在高强度聚集超声治疗子宫肌瘤术中麻醉效果的观察[J]. 徐州医科大学学报, 2023, 43(5): 358-361. DOI: 10.3969/j.issn.2096-3882.2023.05.009
    KONG Deqiang, SONG Yu, CHEN Buze. Observation of the anesthetic effect of different doses of remifentanil combined with dexmedetomidine in the treatment of uterine leiomyomas by high intensity focused ultrasound[J]. Journal of Xuzhou Medical University, 2023, 43(5): 358-361. DOI: 10.3969/j.issn.2096-3882.2023.05.009
    Citation: KONG Deqiang, SONG Yu, CHEN Buze. Observation of the anesthetic effect of different doses of remifentanil combined with dexmedetomidine in the treatment of uterine leiomyomas by high intensity focused ultrasound[J]. Journal of Xuzhou Medical University, 2023, 43(5): 358-361. DOI: 10.3969/j.issn.2096-3882.2023.05.009

    不同剂量瑞芬太尼联合右美托咪定在高强度聚集超声治疗子宫肌瘤术中麻醉效果的观察

    Observation of the anesthetic effect of different doses of remifentanil combined with dexmedetomidine in the treatment of uterine leiomyomas by high intensity focused ultrasound

    • 摘要: 目的 观察术中维持不同剂量的瑞芬太尼在高强度聚集超声(海扶刀)治疗子宫肌瘤术中的麻醉效果。方法 选择有海扶刀治疗指征拟行子宫肌瘤消融术的患者90例。根据手术过程中瑞芬太尼的维持剂量,将患者分为3组:瑞芬太尼低剂量组0.06μg/(kg·h)(L组)、瑞芬太尼中剂量组0.08μg/(kg·h)(M组)和瑞芬太尼高剂量组0.1μg/(kg·h)(H组),每组30例。比较3组患者麻醉开始前即刻(T1)、负荷量右美托咪定泵注完毕后即刻(T2)、手术开始时(T3)、手术开始后10 min(T4)及手术结束后10 min(T5)的平均动脉压(MBP)、心率(HR)、脉搏氧饱和度(SpO2)以及Ramsay镇静评分。记录各组术中需要追加镇痛药物的例数以及低氧血症、心动过缓和低血压等不良反应发生的例数。结果 H组在T4时间点HR低于L组和M组,SpO2低于L组和M组,差异有统计学意义(P<0.05)。T3和T4时间点3组间Ramsay评分比较,差异有统计学意义(P<0.05)。L组术中需要追加瑞芬太尼的例数明显多于M组和H组,H组术中低氧发生率明显高于L组和M组,差异有统计学意义(P<0.05)。结论 术中泵注瑞芬太尼和右美托咪定能够满足海扶刀治疗子宫肌瘤的需求,且以0.08μg/(kg·h)作为瑞芬太尼的起始泵注剂量更为安全有效。

       

      Abstract: Objective To observe the anesthetic effect of different doses of remifentanil combined with dexmedetomidine in the treatment of uterine leiomyomas by high intensity focused ultrasound(Hifu knife).Methods A total of 90 patients who were scheduled for uterine fibroid embolization by Hifu knife were selected. According to the doses of remifentanil for anesthesia maintenance, the patients were divided into three groups: a low-dose remifentanil group(group L) at 0.06 μg/(kg·min), a middle-dose remifentanil group(group M) at 0.08 μg/(kg·min), and a high-dose remifentanil group(group H) at 0.1 μg/(kg·min). The three groups were compared for their mean arterial pressure(MBP), heart rate(HR), pulse oxygen saturation(SpO2) and Ramsay sedation scores immediately before anesthesia(T1), immediately before the end of dexmedetomidine pumping(T2), at the beginning of surgery(T3), 10 min after the surgery started(T4) and 10 min after the surgery finished(T5). In addition, the number of cases requiring additional analgesics and the number of adverse reactions such as hypoxia, bradycardia and hypotension were recorded.Results At T4, group H had slower HR and less SpO2 than group L and group M(P<0.05). At T3 and T4, the difference of Ramsay sedation scores among the three groups was statistically significant. The number of cases requiring additional remifentanil in group L was significantly more than those in group M and group H. The incidence of intraoperative hypoxia in group H was significantly higher than those in group L and group M.Conclusions Remifentanil combined with dexmedetomidine can meet the needs for the treatment of uterine leiomyomas by Haifu knife. After pumping a loading dose of dexmedetomidine, an initial pumping dose of remifentanil at 0.08 μg/(kg·min) is the optimal.

       

    /

    返回文章
    返回